Trial intelligence / Profile preview

Quetiapine Monotherapy in PTSD

NCT00237393Phase 4Completed

Sponsor
Ralph H. Johnson VA Medical Center
Start
Aug 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of quetiapine in post-traumatic stress disorder (PTSD), sponsored by Ralph H. Johnson VA Medical Center. Started Aug 2003; status: completed.

02

Drugs

quetiapine
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT00237393.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00237393.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call